These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 15477396

  • 1. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
    Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.
    Circulation; 2004 Oct 19; 110(16):2287-92. PubMed ID: 15477396
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
    Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW.
    Stroke; 1999 Jun 19; 30(6):1223-9. PubMed ID: 10356104
    [Abstract] [Full Text] [Related]

  • 3. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.
    Pearce LA, Hart RG, Halperin JL.
    Am J Med; 2000 Jul 19; 109(1):45-51. PubMed ID: 10936477
    [Abstract] [Full Text] [Related]

  • 4. Atrial fibrillation and cardioembolic stroke.
    Ferro JM.
    Minerva Cardioangiol; 2004 Apr 19; 52(2):111-24. PubMed ID: 15194993
    [Abstract] [Full Text] [Related]

  • 5. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S, Trappolini M, Chillotti FM.
    Minerva Cardioangiol; 2001 Feb 19; 49(1):1-13. PubMed ID: 11279381
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
    JAMA; 2001 Feb 19; 279(16):1273-7. PubMed ID: 9565007
    [Abstract] [Full Text] [Related]

  • 8. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
    Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R, Nasco E, Sherman DG, Talbert RL, Marler JR, Stroke Prevention in Atrial Fibrillation Investigators.
    Ann Intern Med; 2003 May 20; 138(10):831-8. PubMed ID: 12755555
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
    Gandjour J, Zeindler J, Georgiadis D, Baumgartner RW.
    Praxis (Bern 1994); 2005 Jan 26; 94(4):97-104. PubMed ID: 15732803
    [Abstract] [Full Text] [Related]

  • 11. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
    Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ.
    JAMA; 2001 Jun 13; 285(22):2864-70. PubMed ID: 11401607
    [Abstract] [Full Text] [Related]

  • 12. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.
    Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E.
    Cerebrovasc Dis; 2000 Jun 13; 10(1):39-43. PubMed ID: 10629345
    [Abstract] [Full Text] [Related]

  • 13. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y, Wang H, Tian Y, Wang Y, Lip GYH.
    Chest; 2015 Jul 13; 148(1):62-72. PubMed ID: 25501045
    [Abstract] [Full Text] [Related]

  • 14. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.
    JAMA; 2003 Nov 26; 290(20):2685-92. PubMed ID: 14645310
    [Abstract] [Full Text] [Related]

  • 15. Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients.
    Hess CN, Broderick S, Piccini JP, Alexander KP, Newby LK, Shaw LK, Mahaffey KW, Alexander JH, Peterson ED, Granger CB, Lopes RD.
    Am Heart J; 2012 Oct 26; 164(4):607-15. PubMed ID: 23067921
    [Abstract] [Full Text] [Related]

  • 16. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.
    N Engl J Med; 2003 Sep 11; 349(11):1019-26. PubMed ID: 12968085
    [Abstract] [Full Text] [Related]

  • 17. Guidelines for stroke prevention in patients with atrial fibrillation.
    Howard PA.
    Drugs; 1999 Dec 11; 58(6):997-1009. PubMed ID: 10651387
    [Abstract] [Full Text] [Related]

  • 18. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
    Agarwal S, Hachamovitch R, Menon V.
    Arch Intern Med; 2012 Apr 23; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
    [Abstract] [Full Text] [Related]

  • 19. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials.
    Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC, Albers GW.
    Stroke; 2007 Mar 23; 38(3):874-80. PubMed ID: 17255547
    [Abstract] [Full Text] [Related]

  • 20. Long-term antithrombotic treatment for atrial fibrillation.
    Nademanee K, Kosar EM.
    Am J Cardiol; 1998 Oct 16; 82(8A):37N-42N. PubMed ID: 9809899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.